1. Home
  2. GLDD vs ANAB Comparison

GLDD vs ANAB Comparison

Compare GLDD & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Great Lakes Dredge & Dock Corporation

GLDD

Great Lakes Dredge & Dock Corporation

HOLD

Current Price

$16.94

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

ANAB

AnaptysBio Inc.

HOLD

Current Price

$55.03

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLDD
ANAB
Founded
1890
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2007
2015

Fundamental Metrics

Financial Performance
Metric
GLDD
ANAB
Price
$16.94
$55.03
Analyst Decision
Hold
Strong Buy
Analyst Count
1
10
Target Price
$17.00
$66.70
AVG Volume (30 Days)
2.1M
442.1K
Earning Date
05-26-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
28.57
91.02
EPS
1.08
N/A
Revenue
$702,503,000.00
$234,603,000.00
Revenue This Year
$3.79
N/A
Revenue Next Year
$9.01
$43.04
P/E Ratio
$15.70
N/A
Revenue Growth
N/A
157.01
52 Week Low
$7.51
$15.32
52 Week High
$16.99
$63.47

Technical Indicators

Market Signals
Indicator
GLDD
ANAB
Relative Strength Index (RSI) 68.29 54.46
Support Level $14.60 $43.67
Resistance Level $16.99 $57.70
Average True Range (ATR) 0.05 3.58
MACD -0.09 -0.02
Stochastic Oscillator 65.38 25.30

Price Performance

Historical Comparison
GLDD
ANAB

About GLDD Great Lakes Dredge & Dock Corporation

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: